EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Direct Oral Healthcare Costs Associated With Xerostomia and Hyposalivation: A Scoping Review and Annual Cost Synthesis

Mateus José Dutra, Manoela Domingues Martins, Naile Dame‐Teixeira, Vivian Petersen Wagner

Oral Diseases · 2026-11-05

DOI: 10.1111/odi.70565 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective To map the available evidence on direct oral healthcare costs associated with xerostomia and hyposalivation. Methods A scoping review was conducted following PRISMA‐ScR guidelines. Searches were performed in PubMed, Scopus, Embase, and Web of Science, with additional screening of gray literature. Studies reporting direct oral healthcare costs associated with xerostomia or/and hyposalivation were eligible. Reported costs were standardized to a common currency and price year. Exploratory annual cost scenarios were generated by combining reported unit costs with reported guideline‐based or hypothetical frequencies. Results Eight studies met the inclusion criteria. Six (75%) were conducted in the United States and two (25%) in the United Kingdom. Reported cost components included dental consultations, salivary stimulants and substitutes, restorative treatments, dental implants, fluoride applications, and management of oral infections. Evidence was heterogeneous in populations, etiologies, healthcare settings, cost components, and reporting methods. Illustrative base‐case scenarios ranged from USD 3296.08 to USD 10,414.51 per patient per year (USD 1791.23–5658.99 when hypothetical events and possible overlaps were excluded). Conclusion The evidence base is limited and heterogeneous. The exploratory annual synthesis provides an initial framework for mapping reported cost components but does not represent a definitive estimate of economic burden.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →